Portfolio
Advancing Portfolio
Screening Program
- RFP Year2017
- Awarded Amount$65,836
- DiseaseMalaria
- InterventionDrug
- Development StageHit Identification
- Collaboration PartnersAstellas Pharma Inc., Medicines for Malaria Venture (MMV)